C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/395 (2006.01) C07K 14/485 (2006.01) C07K 14/73 (2006.01) C07K 16/18 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/13 (2006.01) C12N 15/16 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2095842
2095842 9208801 PCTABS00013 Disclosed is a bridging antibody construct including a heavy chain variable region which, when combined with a light chain variable region, binds to a surface antigen on an effector cell; a heavy chain constant region comprising a CH3 domain; and a non-immunoglobulin binding agent which binds a surface protein on a target cell. The binding agent is peptide-bonded to the carboxy terminus of said CH3 domain. Also disclosed are a nucleic acid sequence encoding the construct, a cell line transfected with that nucleic acid, a method of producing the construct, and methods of selectively killing a target cell using the construct.
Abbott Laboratories
Kirby Eades Gale Baker
Repligen Corporation
LandOfFree
Bridging antibody fusion constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bridging antibody fusion constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridging antibody fusion constructs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1491423